TheraBionic Inc. is an innovative medical device company focused on transforming the lives of patients with difficult to treat cancers. TheraBionic Inc. patented low-level, tumor-specific radio frequencies administered via the TheraBionic P1 device is FDA approved in the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer. The results of more than two decades of studies have indicated that the tumor-specific radio frequencies are effective in tumor shrinkage, blocking new cancer cell growth, and overall increased survival rates.

TheraBionic Inc.

Org chart

Teams

Offices

TheraBionic Inc.

Org chart

Teams

Offices

Related companies